Correlation Between SAB Biotherapeutics and Phio Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both SAB Biotherapeutics and Phio Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining SAB Biotherapeutics and Phio Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between SAB Biotherapeutics and Phio Pharmaceuticals Corp, you can compare the effects of market volatilities on SAB Biotherapeutics and Phio Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in SAB Biotherapeutics with a short position of Phio Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of SAB Biotherapeutics and Phio Pharmaceuticals.
Diversification Opportunities for SAB Biotherapeutics and Phio Pharmaceuticals
-0.35 | Correlation Coefficient |
Very good diversification
The 3 months correlation between SAB and Phio is -0.35. Overlapping area represents the amount of risk that can be diversified away by holding SAB Biotherapeutics and Phio Pharmaceuticals Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Phio Pharmaceuticals Corp and SAB Biotherapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on SAB Biotherapeutics are associated (or correlated) with Phio Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Phio Pharmaceuticals Corp has no effect on the direction of SAB Biotherapeutics i.e., SAB Biotherapeutics and Phio Pharmaceuticals go up and down completely randomly.
Pair Corralation between SAB Biotherapeutics and Phio Pharmaceuticals
Assuming the 90 days horizon SAB Biotherapeutics is expected to generate 4.06 times more return on investment than Phio Pharmaceuticals. However, SAB Biotherapeutics is 4.06 times more volatile than Phio Pharmaceuticals Corp. It trades about 0.14 of its potential returns per unit of risk. Phio Pharmaceuticals Corp is currently generating about -0.08 per unit of risk. If you would invest 5.44 in SAB Biotherapeutics on August 24, 2024 and sell it today you would earn a total of 1.25 from holding SAB Biotherapeutics or generate 22.98% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 86.96% |
| Values | Daily Returns |
SAB Biotherapeutics vs. Phio Pharmaceuticals Corp
Performance |
| Timeline |
| SAB Biotherapeutics |
| Phio Pharmaceuticals Corp |
SAB Biotherapeutics and Phio Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with SAB Biotherapeutics and Phio Pharmaceuticals
The main advantage of trading using opposite SAB Biotherapeutics and Phio Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if SAB Biotherapeutics position performs unexpectedly, Phio Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Phio Pharmaceuticals will offset losses from the drop in Phio Pharmaceuticals' long position.| SAB Biotherapeutics vs. Lyra Therapeutics | SAB Biotherapeutics vs. Hookipa Pharma | SAB Biotherapeutics vs. Cingulate Warrants | SAB Biotherapeutics vs. SAB Biotherapeutics |
| Phio Pharmaceuticals vs. Zura Bio Limited | Phio Pharmaceuticals vs. Immix Biopharma | Phio Pharmaceuticals vs. Cns Pharmaceuticals | Phio Pharmaceuticals vs. ZyVersa Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.
Other Complementary Tools
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Stocks Directory Find actively traded stocks across global markets |